Clinical Trials Logo
  1. Home
  2. Rectal Cancer
  3. NCT04622176
  4. Details
NCT04622176 Clinical Trial

Magnetomotoric Ultrasound for Diagnostic Purposes in Rectal Cancer

Rectal Cancer Clinical Trial

— MMURC  

Official title:
Magnetomotoric Ultrasound for Diagnostic Purposes in Rectal Cancer

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04622176
Other study ID # MMURC
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 17, 2021
Est. completion date December 1, 2025

Study information
Verified date December 2023
Source Sahlgrenska University Hospital, Sweden
Contact Eva Angenete, MD. PhD
Phone +46760-514441
Email eva.angenete@vgregion.se
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A magnetomotive ultrasound combines standard diagnostic ultrasound equipment with the application of an external time-varying magnetic field. The investigators aim to use this equipment to improve preoperative diagnostics in rectal cancer.

Description:

The investigators will compare magnetomotive ultrasound with MRI and pathology report on specimens extracted during surgery.

Recruitment information / eligibility
Status Recruiting
Enrollment 28
Est. completion date December 1, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Rectal cancer - Surgery with abdominoperineal resection Exclusion Criteria: - No informed consent - Not fulfilling inclusion criteria - No rectal cancer

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• MMUS
MMUS will be used to perform diagnostics, we will compare with MRI and histology

Locations
Country Name City State
Sweden Dept. of Surgery, Sahlgrenska University Hospital/Ostra Gothenburg

Sponsors (2)
Lead Sponsor Collaborator
Sahlgrenska University Hospital, Sweden Lund University

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary Accuracy of lymph node diagnosis compared to pathology report Accuracy of lymph node diagnosis - a comparison between the findings with the device and the pathology report 1 hour postoperatively
Primary Accuracy of lymph node diagnosis compared to MRI Accuracy of lymph node diagnosis compared to MRI 1 hour postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT06380101 - Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) N/A
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT04323722 - Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Active, not recruiting NCT01347697 - Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer N/A
Recruiting NCT04495088 - Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer Phase 3
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Not yet recruiting NCT03520088 - PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS N/A
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT04749381 - The Role of TCM on ERAS of Rectal Cancer Patients Phase 2
Enrolling by invitation NCT05028192 - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Recruiting NCT03283540 - Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Completed NCT04534309 - Behavioral Weight Loss Program for Cancer Survivors in Maryland N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Recruiting NCT04852653 - A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Terminated NCT02933944 - Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer Phase 1
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A